Form 4: Alignment Healthcare's Chief Medical Officer, Hyong Kim, Sells Shares Under 10b5-1 Plan

Hyong Kim, Chief Medical Officer of Alignment Healthcare, sold shares of common stock on March 7, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• On March 7, 2025, Hyong Kim, the Chief Medical Officer of Alignment Healthcare, sold shares of the company's common stock.
• The sales were executed under a pre-arranged trading plan pursuant to Rule 10b5-1(c), which was adopted on September 5, 2024.
• A total of 21,006 shares were sold at a weighted average price of $15.0451, with individual prices ranging from $14.60 to $15.59.
• An additional 568 shares were sold at a weighted average price of $15.6515, with individual prices ranging from $15.62 to $15.70.
• Following these transactions, Kim directly owns 486,302 shares of Alignment Healthcare common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard Form 4 filing reporting an insider's stock sale under a pre-arranged plan. There's no indication of positive or negative implications for the company.

Industry Context

This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a change in the company's outlook or performance. It's common for executives to sell shares for personal financial planning reasons.

Stakeholder Impact

• The share sales by a key executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates